Open Access
| Issue |
BIO Web Conf.
Volume 198, 2025
5th ASEAN Microbial Biotechnology Conference (AMBC 2025)
|
|
|---|---|---|
| Article Number | 02001 | |
| Number of page(s) | 12 | |
| Section | Biochemistry | |
| DOI | https://doi.org/10.1051/bioconf/202519802001 | |
| Published online | 03 December 2025 | |
- T. Baram, N. Oren, N. Erlichman, T. Meshel, A. Ben-Baruch, Inflammation-driven regulation of PD-L1 and PD-L2, and their cross-interactions with protective soluble TNFa receptors in human triple-negative breast cancer. Cancers. 14, 3513 (2022). https://doi.org/10.3390/cancers14143513 [Google Scholar]
- E. Garcia, I. Luna, K.L. Persad, K. Agopsowicz, D.A. Jay, F.G. West, M.M. Hitt, S. Persad, Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition. Sci. Rep. 11, 11757 (2021). https://doi.org/10.1038/s41598-021-91344-7 [Google Scholar]
- M.F. Mercogliano, S. Bruni, P.V. Elizalde, R. Schillaci, Tumor necrosis factor á blockade: An opportunity to tackle breast cancer. Front. Oncol. 10, 584 (2020). https://doi.org/10.3389/fonc.2020.00584 [Google Scholar]
- H. Narasimhan, F. Ferraro, A. Bleilevens, R. Weiskirchen, E. Stickeler, J. Maurer, Tumor necrosis factor-á (TNFa) stimulates triple-negative breast cancer stem cells to promote intratumoral invasion and neovasculogenesis in the liver of a xenograft model. Biology. 11, 1481 (2022). https://doi.org/10.3390/biology11101481 [Google Scholar]
- Y. Wu, Z. Yang, K. Cheng, H. Bi, J. Chen, Small molecule-based immunomodulators for cancer therapy. Acta Pharm. Sin. B. 12, 4287 (2022). https://doi.org/10.1016/j.apsb.2022.11.007 [Google Scholar]
- A.H. Ramadhani, W. Nafisah, H. Isnanto, T.K. Sholeha, Y.D. Jatmiko, H. Tsuboi, M. Rifa'i, Immunomodulatory effects of Cyperus rotundus extract on 7,12 dimethylbenz[a]anthracene (DMBA) exposed BALB/c mice. Pharm. Sci. 27, 46 (2020). https://doi.org/10.34172/PS.2020.61 [Google Scholar]
- W. Nafisah, F. Fatchiyah, M.H. Widyananda, Y.I. Christina, M. Rifa'i, N. Widodo, M.S. Djati, Potential of bioactive compound of Cyperus rotundus L. rhizome extract as inhibitor of PD-L1/PD-1 interaction: An in silico study. Agric. Nat. Resour. 56, 751 (2022). [Google Scholar]
- W. Nafisah, N. Wahyuningsih, M.F. Maulana, S.Z.K. Azmi, M. Rifa'i, N. Widodo, M.S. Djati, Cyperus rotundus L. rhizome extract modulates immune system and induces apoptotic in 4T1-tumor bearing mice. J. Pharm. Pharmacogn. Res. 11, 674 (2023). https://doi.org/10.56499/jppres23.1604 11.4.674 [Google Scholar]
- D. Shi, P. Jiang, A different facet of p53 function: Regulation of immunity and inflammation during tumor development. Front. Cell Dev. Biol. 9, 762651 (2021). https://doi.org/10.3389/fcell.2021.762651 [Google Scholar]
- V. Salemme, G. Centonze, F. Cavallo, P. Defilippi, L. Conti, The crosstalk between tumor cells and the immune microenvironment in breast cancer: Implications for immunotherapy. Front. Oncol. 11, 610303 (2021). https://doi.org/10.3389/fonc.2021.610303 [Google Scholar]
- R. Vishnubalaji, N.M. Alajez, Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-â signaling. Sci. Rep. 11, 15410 (2021). https://doi.org/10.1038/s41598-021-94514-9 [Google Scholar]
- X. Xu, L. Zhang, X. He, P. Zhang, C. Sun, X. Xu, Y. Lu, F. Li, TGF-â plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating sternness, EMT and apoptosis. Biochem. Biophys. Res. Commun. 502, 160 (2018). https://doi.org/10.1016/i.bbrc.2018.05.139 [Google Scholar]
- E. Sheikhpour, P. Noorbakhsh, E. Foroughi, S. Farahnak, R. Nasiri, H. Neamatzadeh, A survey on the role of interleukin-10 in breast cancer: A narrative. Rep. Biochem. Mol. Biol. 7, 30 (2018). [Google Scholar]
- B. Mirlekar, Tumor promoting roles of IL-10, TGF-â, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Med. 10, 1 (2022). https://doi.org/10.1177/20503121211069012 [Google Scholar]
- J. Cai, D. Wang, G. Zhang, X. Guo, The role Of PD-1/PD-L1 axis in Treg development and function: Implications for cancer immunotherapy. OncoTargets Ther. 12, 8437 (2019). https://doi.org/10.2147/OTT.S221340 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.